6 September 2021 - PHARMAC has today announced that Roche, the global pharmaceutical company which provides tocilizumab, will not provide New Zealand with product for the next three months, due to massive demand worldwide.

“We have been in regular contact with Roche over the past 12 months to ensure continuity of supply of tocilizumab. Roche assured PHARMAC there would be no issues. However, Roche has now told PHARMAC it is out of stock and cannot meet its contracted obligations to provide New Zealand with normal volumes of tocilizumab.”

Read PHARMAC press release